It might sound straightforward, but in reality goes way beyond just commercial and R&D process, and is underpinned by the very culture of the organisation.īeing brave is in Celgene’s DNA. Indeed, a fundamental tenet of his strategy for Celgene has been the concept of the ‘virtuous cycle of innovation’, which he describes as “adopting a transformational, disruptive business model with the patient at the centre, by focusing on tremendous operating excellence with the existing portfolio, which allows reinvestment in areas of high potential, where science and unmet need overlap”. But forward movement is critical – Hugin has no time for ‘me too’ products.
However, he also accepts that such transformational leaps can sometimes come from smaller steps, recognising the value of incremental innovation in difficult to tackle areas such as cancer and neurodegenerative disorders.
“If we’re not helping patients in a significant way, there is no business model”, Hugin states boldly, before going on to confirm that “pharma is a big part of the solution – we have the potential as an industry to make transformational changes to the lives of patients”. “If we’re not helping patients in a significant way, there is no business model”įor Hugin, he sees this appointment as an important opportunity to help communicate his broader passion for the industry’s work, while also recognising the dual challenges of having to adapt pharma’s business model and better communicate its work. Now, after only three years in the top job, he has also been elected as Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) a real endorsement of how respected Celgene’s work is by the broader pharma industry. The current Chief Executive Officer and Chairman, Robert Hugin, better known as Bob, has seen the company’s growth first-hand, since joining in 1999 as Chief Financial Officer. Since then, it has established a reputation for not only innovative science, but also calculated risk-taking, perhaps best exemplified by bringing the older drug thalidomide back to the market in the 1990s as an effective anti-cancer agent, despite its chequered past. Given the strong presence Celgene has established in oncology, it is hard to believe that the corporation has been around for barely more than a quarter of a century, starting life as an independent biotechnology company in 1986, before conducting an IPO the following year. You can check the table to know about marital status and other information.As pharmaphorum continues to connect with those senior executives who are shaping the future of the pharmaceutical industry, Paul Tunnah speaks with the CEO of global biopharmaceutical company Celgene, Bob Hugin, to hear about the virtuous cycle of innovation. We have tried to cover their favorite things and personalities here. We have tried to show you his hobbies, marital status, affairs and many other personal stuffs through a table below. Bob Hugin Marital Status and girlfriendĭo you know with whom He engaged now? If you are interested enough about personal life, you get all the personal info here. As the weight changes regularly we put the current value. Idol’s physical state, height, weight even the hairstyle is followed by the fans. Many of the followers always try to learn about the physic of their favorite celebrities. Robert John Hugin Height and Physical Description
The location of his birth is Jersey City, New Jersey, U.S. You may hear that his birthday is on 23-Jul-54. Is the age of Robert John Hugin is a mystery to you? You can find it here if you don’t know about him birthday or birthplace and other facts related to this. To get more information check the below table section. The name of his home town is Jersey City, New Jersey, U.S. The birth name of this American Businessman is Robert John Hugin.
0 kommentar(er)
